In addition to the adaptive increase of blood adiponectin level, insulin resistance or compromised insulin receptor signaling pathway may downregulate expression of insulin degrading enzyme (IDE), a downstream target of the pathway and protease that digests Aβ as well as insulin [69]. The gene discussed is ADIPOQ; the disease is Insulin resistance.